These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9016896

  • 1. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients.
    Peces R, de la Torre M, Alcázar R, Urra JM.
    Am J Kidney Dis; 1997 Feb; 29(2):239-45. PubMed ID: 9016896
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
    el-Reshaid K, al-Mufti S, Johny KV, Sugathan TN.
    Vaccine; 1994 Feb; 12(3):223-34. PubMed ID: 8165854
    [Abstract] [Full Text] [Related]

  • 3. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D.
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
    Asan A, Demirhan H, Sorkun HÇ, Özkan S, Aydın M, Akın D, Tatar B, Çatak B, Şener A, Köse Ş.
    Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
    [Abstract] [Full Text] [Related]

  • 5. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
    Kayataş M.
    Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
    [Abstract] [Full Text] [Related]

  • 6. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B.
    Vaccine; 2004 Sep 28; 22(29-30):3963-7. PubMed ID: 15364445
    [Abstract] [Full Text] [Related]

  • 7. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
    Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuno J.
    Am J Nephrol; 1996 Sep 28; 16(2):95-7. PubMed ID: 8919223
    [Abstract] [Full Text] [Related]

  • 8. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis].
    Pin M, Compte MT, Angelet P, Gállego C, Gutiérrez C, Martinez Vea A.
    Nefrologia; 2009 Sep 28; 29(5):415-20. PubMed ID: 19820753
    [Abstract] [Full Text] [Related]

  • 9. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response.
    Peces R, Laurés AS.
    Nephron; 2001 Oct 28; 89(2):172-6. PubMed ID: 11549899
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.
    Z Gastroenterol; 2003 Oct 28; 41(10):983-90. PubMed ID: 14562195
    [Abstract] [Full Text] [Related]

  • 11. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?
    Jadoul M, Goubau P.
    Clin Nephrol; 2002 Oct 28; 58(4):301-4. PubMed ID: 12400846
    [Abstract] [Full Text] [Related]

  • 12. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status.
    Ibrahim S, el-Din S, Bazzal I.
    J Natl Med Assoc; 2006 Dec 28; 98(12):1953-7. PubMed ID: 17225840
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection.
    Cheng CH, Huang CC, Leu ML, Chiang CY, Wu MS, Lai PC.
    Vaccine; 1997 Dec 28; 15(12-13):1353-7. PubMed ID: 9302744
    [Abstract] [Full Text] [Related]

  • 14. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
    Lin SY, Liu JH, Lin CC, Wang SM, Tsai CA, Chou CY, Kuo HL, Wang IK, Liu YL, Lin HH, Huang CC.
    Vaccine; 2011 May 12; 29(21):3738-41. PubMed ID: 21458609
    [Abstract] [Full Text] [Related]

  • 15. Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population.
    Charest AF, Grand'Maison A, McDougall J, Goldstein MB.
    Am J Kidney Dis; 2003 Dec 12; 42(6):1193-9. PubMed ID: 14655191
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
    Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Maziar S, Razeghi E, Kalantar E, Amirkhani A, Aghakhani A.
    Int J Clin Pract; 2009 Mar 12; 63(3):394-7. PubMed ID: 18005039
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
    Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, Robbins KC, Kobetitsch JF, McDaniel A, D'Avella JF, Alter MJ.
    Vaccine; 2011 Dec 06; 29(52):9618-23. PubMed ID: 22044739
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.